
William A. Craigo
Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 936 |
| Issued Applications | 383 |
| Pending Applications | 126 |
| Abandoned Applications | 445 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17828402
[patent_doc_number] => 20220265706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING COMPLEXES OF ALLOFERON AND ZINC
[patent_app_type] => utility
[patent_app_number] => 17/627741
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627741
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627741 | PHARMACEUTICAL COMPOSITION CONTAINING COMPLEXES OF ALLOFERON AND ZINC | Dec 10, 2020 | Abandoned |
Array
(
[id] => 20301223
[patent_doc_number] => 12447193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Compositions and methods for prevention and treatment of infections
[patent_app_type] => utility
[patent_app_number] => 17/102081
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 26
[patent_no_of_words] => 7192
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102081
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102081 | Compositions and methods for prevention and treatment of infections | Nov 22, 2020 | Issued |
Array
(
[id] => 16853628
[patent_doc_number] => 20210154373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => METHOD FOR IMMOBILIZING HEPARIN AND NO-GENERATING CATALYST AND CARDIOVASCULAR DEVICE HAVING SURFACE MODIFIED USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/952627
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952627
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952627 | METHOD FOR IMMOBILIZING HEPARIN AND NO-GENERATING CATALYST AND CARDIOVASCULAR DEVICE HAVING SURFACE MODIFIED USING THE SAME | Nov 18, 2020 | Abandoned |
Array
(
[id] => 17593322
[patent_doc_number] => 20220142895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => USE OF SALIDROSIDE DERIVATIVE IN EXTERNAL PREPARATION FOR SKIN WHITENING
[patent_app_type] => utility
[patent_app_number] => 17/432492
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432492 | Use of salidroside derivative in external preparation for skin whitening | Nov 17, 2020 | Issued |
Array
(
[id] => 16822677
[patent_doc_number] => 20210137970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => NITRIC OXIDE-RELEASING PARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/090637
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090637
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/090637 | NITRIC OXIDE-RELEASING PARTICLES | Nov 4, 2020 | Pending |
Array
(
[id] => 17602846
[patent_doc_number] => 11331315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Aripiprazole oral soluble film
[patent_app_type] => utility
[patent_app_number] => 17/087949
[patent_app_country] => US
[patent_app_date] => 2020-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5782
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087949
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/087949 | Aripiprazole oral soluble film | Nov 2, 2020 | Issued |
Array
(
[id] => 18018815
[patent_doc_number] => 20220370314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => AQUEOUS OXIDATIVE COMPOSITION COMPRISING XANTHINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/773517
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773517
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773517 | AQUEOUS OXIDATIVE COMPOSITION COMPRISING XANTHINE DERIVATIVES | Oct 29, 2020 | Pending |
Array
(
[id] => 18064520
[patent_doc_number] => 20220395607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => SWELLABLE ANTIMICROBIAL FIBRE
[patent_app_type] => utility
[patent_app_number] => 17/771276
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/771276 | SWELLABLE ANTIMICROBIAL FIBRE | Oct 21, 2020 | Abandoned |
Array
(
[id] => 18018989
[patent_doc_number] => 20220370488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => MUCUS PENETRATING PARTICLE COMPOSITIONS AND METHODS OF USE THEREOF ENHANCING IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/770437
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770437 | MUCUS PENETRATING PARTICLE COMPOSITIONS AND METHODS OF USE THEREOF ENHANCING IMMUNE RESPONSE | Oct 20, 2020 | Pending |
Array
(
[id] => 20401193
[patent_doc_number] => 12491152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Antiperspirant/deodorant compositions
[patent_app_type] => utility
[patent_app_number] => 17/763386
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5023
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763386
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763386 | Antiperspirant/deodorant compositions | Oct 15, 2020 | Issued |
Array
(
[id] => 16748729
[patent_doc_number] => 20210100738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => OXYGEN DELIVERY BEVERAGE
[patent_app_type] => utility
[patent_app_number] => 17/069394
[patent_app_country] => US
[patent_app_date] => 2020-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17069394
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/069394 | OXYGEN DELIVERY BEVERAGE | Oct 12, 2020 | Abandoned |
Array
(
[id] => 16596519
[patent_doc_number] => 20210023050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => TESOFENSINE AND BETA BLOCKER COMBINATION FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/066843
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17066843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/066843 | Tesofensine and beta blocker combination formulations | Oct 8, 2020 | Issued |
Array
(
[id] => 16805983
[patent_doc_number] => 20210128536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => WEAKLY BASIC DRUG AND IONIC POLYMER PHARMACEUTICAL FORMULATIONS AND METHODS OF FORMATION AND ADMINISTRATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/065664
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/065664 | WEAKLY BASIC DRUG AND IONIC POLYMER PHARMACEUTICAL FORMULATIONS AND METHODS OF FORMATION AND ADMINISTRATION THEREOF | Oct 7, 2020 | Abandoned |
Array
(
[id] => 19777531
[patent_doc_number] => 12226552
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Active agent depots formed in situ
[patent_app_type] => utility
[patent_app_number] => 17/038171
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 11096
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17038171
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/038171 | Active agent depots formed in situ | Sep 29, 2020 | Issued |
Array
(
[id] => 20592360
[patent_doc_number] => 12576056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Amino acid-containing granules
[patent_app_type] => utility
[patent_app_number] => 17/761760
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4834
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761760
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761760 | Amino acid-containing granules | Sep 17, 2020 | Issued |
Array
(
[id] => 17958504
[patent_doc_number] => 20220339084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => NEAR INFRARED BLOCKING AGENT AND NEAR INFRARED BLOCKING TOPICAL SKIN PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/762856
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762856
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762856 | NEAR INFRARED BLOCKING AGENT AND NEAR INFRARED BLOCKING TOPICAL SKIN PREPARATION | Sep 17, 2020 | Pending |
Array
(
[id] => 16718601
[patent_doc_number] => 20210085748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => Implantable medical device having a negatively-charged and antimicrobial surface
[patent_app_type] => utility
[patent_app_number] => 17/024343
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17024343
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/024343 | Implantable medical device having a negatively-charged and antimicrobial surface | Sep 16, 2020 | Abandoned |
Array
(
[id] => 18341268
[patent_doc_number] => 11638737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Food compositions and pharmaceutical compositions containing
[patent_app_type] => utility
[patent_app_number] => 17/023447
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10829
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17023447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/023447 | Food compositions and pharmaceutical compositions containing | Sep 16, 2020 | Issued |
Array
(
[id] => 16718455
[patent_doc_number] => 20210085602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => INJECTABLE PHARMACEUTICAL FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/015415
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/015415 | Injectable pharmaceutical formulation | Sep 8, 2020 | Issued |
Array
(
[id] => 16655944
[patent_doc_number] => 20210052580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => Combination Compositions and Therapies Comprising 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, and Methods of Making and Using Same
[patent_app_type] => utility
[patent_app_number] => 17/013142
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/013142 | Combination Compositions and Therapies Comprising 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, and Methods of Making and Using Same | Sep 3, 2020 | Abandoned |